TIDMIDEA
RNS Number : 1543K
Ideagen PLC
11 December 2018
Ideagen PLC
("Ideagen," "the Company" or the "Group")
Issue of new shares under the Share Incentive Plan, Director
Dealings and Total Voting Rights
Ideagen PLC (AIM: IDEA), a leading supplier of Information
Management Software to highly regulated industries, announces that
it has allotted a total of 15,547 new ordinary shares of 1 penny
each in the capital of the Company ("Ordinary Shares") following
the purchase of 14,583 Ordinary Shares by a number of employees
under the Company's Share Incentive Plan ("SIP") and the purchase
of 964 Ordinary Shares following the automatic re-investment of
dividends received in respect of shares held in the SIP.
Application has been made to the London Stock Exchange for the
15,547 new Ordinary Shares to be admitted to trading on AIM
("Admission") and it is expected that Admission will become
effective and trading will commence at 8.00 a.m. on 17 December
2018.
After Admission, the total number of Ordinary Shares in issue
will be 219,239,560 and the total number of voting rights will
therefore be 219,239,560. This figure may be used by shareholders
as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a
change to their interest in, the share capital of the Company under
the FCA's Disclosure and Transparency Rules.
Each of the executive directors of the Company; David Hornsby,
Ben Dorks, Graeme Spenceley and Barney Kent have purchased 6
Ordinary Shares as part this share allotment resulting from the
automatic re-investment of dividends received on their shares held
in the SIP. These directors now have the following interests in the
share capital of the company.
Executive Director Previous shareholding New shareholding % of issued share
capital held
David Hornsby 8,650,057 8,650,063 3.9%
---------------------- ----------------- ------------------
Ben Dorks 2,000,524 2,000,530 0.9%
---------------------- ----------------- ------------------
Graeme Spenceley 828,244 828,250 0.4%
---------------------- ----------------- ------------------
Barney Kent 2,278,184 2,278,190 1.0%
---------------------- ----------------- ------------------
In addition, Alan Carroll, a non-executive director, yesterday
purchased 102 ordinary shares in the Company at a price of 132.7
pence each as a result of the automatic reinvestment of the
Company's recent dividend by his nominated broker.
Following the purchase, Mr Carroll's beneficial interest has
increased to 204,123 shares representing approximately 0.1% of the
Company's issued ordinary share capital.
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) No 596/2014.
Enquiries:
Ideagen plc 01629 699100
David Hornsby, Executive Chairman
Ben Dorks, Chief Executive Officer
Graeme Spenceley, Finance Director
finnCap Limited 020 7220 0500
Stuart Andrews/Henrik Persson/James Thompson
(Nomad)
Alice Lane (ECM)
About Ideagen plc
Ideagen is a UK-headquartered, global technology company quoted
on the London Stock Exchange AIM market (Ticker: IDEA.L).
The Group provides software and services to organisations
operating within highly regulated industries such as aviation,
banking and finance and life science, with its main operational
premises spread throughout the UK, EU, US, Middle East and SE
Asia.
With an excellent portfolio of software products including
Q-Pulse, Coruson, Pentana Audit, Pentana Performance and
PleaseReview, Ideagen helps its clients reduce costs, improve
operational efficiency, strengthen compliance and oversight and
anticipate and manage every detail of risk.
Currently, more than 3,700 organisations use Ideagen's products
including seven of the top 10 UK accounting firms, all of the top
aerospace and defence companies and 75% of the world's leading
pharmaceutical firms.
Ideagen's diverse and varied customer base includes many
well-known, global brands such as British Airways, Aggreko, BAE,
Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank,
Meggitt, Heineken, Johnson Matthey, Haeco Group and European
Central Bank. As well as this, Ideagen counts 180 hospitals across
the UK and US amongst its client base.
For further information please visit www.ideagen.com.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name David Hornsby
2. Reason for the Notification
a) Position/status Executive Chairman
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
a) Name Ideagen plc
b) LEI 213800KS1MLITOVNYC85
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
a) Description of the Financial instrument, type of Ordinary Shares of 1p each
instrument
Identification code GB00B0CM0C50
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s) Price(s) Volume(s)
143p 6
d) Aggregated information: 6 ordinary shares of 1p each purchased at 143p per
-- Aggregated volume share
-- Price
e) Date of the transaction 11 December 2018
f) Place of the transaction London Stock Exchange AIM market (XLON)
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name Graeme Spenceley
2. Reason for the Notification
a) Position/status CFO
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
a) Name Ideagen plc
b) LEI 213800KS1MLITOVNYC85
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
a) Description of the Financial instrument, type of Ordinary Shares of 1p each
instrument
Identification code GB00B0CM0C50
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s) Price(s) Volume(s)
143p 6
d) Aggregated information: 6 ordinary shares of 1p each purchased at 143p per
-- Aggregated volume share
-- Price
e) Date of the transaction 11 December 2018
f) Place of the transaction London Stock Exchange AIM market (XLON)
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name Ben Dorks
2. Reason for the Notification
a) Position/status CEO
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
a) Name Ideagen plc
b) LEI 213800KS1MLITOVNYC85
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
a) Description of the Financial instrument, type of Ordinary Shares of 1p each
instrument
Identification code GB00B0CM0C50
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s) Price(s) Volume(s)
143p 6
d) Aggregated information: 6 ordinary shares of 1p each purchased at 143p per
-- Aggregated volume share
-- Price
e) Date of the transaction 11 December 2018
f) Place of the transaction London Stock Exchange AIM market (XLON)
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name Barnaby Kent
2. Reason for the Notification
a) Position/status Chief Operating Officer
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
a) Name Ideagen plc
b) LEI 213800KS1MLITOVNYC85
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
a) Description of the Financial instrument, type of Ordinary Shares of 1p each
instrument
Identification code GB00B0CM0C50
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s) Price(s) Volume(s)
143p 6
d) Aggregated information: 6 ordinary shares of 1p each purchased at 143p per
-- Aggregated volume share
-- Price
e) Date of the transaction 11 December 2018
f) Place of the transaction London Stock Exchange AIM market (XLON)
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name Alan Carroll
2. Reason for the Notification
a) Position/status Non-Executive Director
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
a) Name Ideagen plc
b) LEI 213800KS1MLITOVNYC85
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
a) Description of the Financial instrument, type of Ordinary Shares of 1p each
instrument
Identification code GB00B0CM0C50
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s) Price(s) Volume(s)
132.7p 102
d) Aggregated information: 102 ordinary shares of 1p each purchased at 132.7p per
-- Aggregated volume share
-- Price
e) Date of the transaction 10 December 2018
f) Place of the transaction London Stock Exchange AIM market (XLON)
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCFFEFIFFASEDE
(END) Dow Jones Newswires
December 11, 2018 10:37 ET (15:37 GMT)
Ideagen (LSE:IDEA)
Historical Stock Chart
From Apr 2024 to May 2024
Ideagen (LSE:IDEA)
Historical Stock Chart
From May 2023 to May 2024